Apyx Medical Corporation
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Apyx Medical Corporation now
Current reporting with the operating signal separated from the noise.
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
The story matters when it changes Apyx Medical Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
The story matters when it changes Apyx Medical Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity
Investors are testing whether Apyx Medical Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction
The story matters when it changes Apyx Medical Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript
Investors are testing whether Apyx Medical Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Apyx Medical Corporation (APYX) Q1 2025 Earnings Call Transcript
Investors are testing whether Apyx Medical Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
The story matters when it changes Apyx Medical Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
The story matters when it changes Apyx Medical Corporation’s customers, execution, competitive position or capital requirements.
Watch next: regulator filings, verified operating scope and liability disclosures.Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
The story matters when it changes Apyx Medical Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest APYX filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Apyx Medical Corporation, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →